Systematic review and meta-analysis of non-invasive prenatal DNA testing for trisomy 21: implications for implementation in China.

Jiajie JinJunwen YangYingyao ChenJiayan Huang

Published in: Prenatal diagnosis (2017)

MPS technology offers effective screening performance for trisomy 21 but should be cautiously promoted due to its clinical limitations and challenges that stem from the ethics and business aspects. © 2017 John Wiley & Sons, Ltd.

Keyphrases

primary care
public health
pregnant women
circulating tumor
healthcare
single molecule
cell free
big data
quality improvement